Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06234995 · ClinicalTrials.gov registry record · Phase 4

Cortical Electrophysiology of Response Inhibition in Parkinson's Disease

A Phase 4 study of Parkinson Disease, sponsored by Emory University.

Recruiting
Registry status
Phase 4
Development phase
80
Enrollment target
2
Study locations

NCT06234995 is a Phase 4 study of Parkinson Disease that is actively recruiting participants, run by Emory University. The registered enrollment target is 80 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06234995, a Phase 4 study of Parkinson Disease, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
Phase 4
Development phase
80 participants
Enrollment target
2
Study locations

Study Summary

Patients with Parkinson's Disease will be studied before, during, and after a deep brain stimulation implantation procedure to see if the stimulation location and the size of the electrical field produced by subthalamic nucleus (STN) DBS determine the degree to which DBS engages circuits that involve prefrontal cortex executive functions, and therefore have a direct impact on the patient's ability to inhibit actions.

Conditions Studied

Parkinson Disease

Interventions

  • DRUG Levodopa
  • DEVICE Clinical DBS Setting
  • DEVICE Sham DBS
  • DEVICE DBS Setting Maximizing Prefrontal Activation
  • DEVICE DBS Setting Minimizing Prefrontal Activation

Study Locations (2)

Georgia

  • Emory University Hospital - Atlanta
  • Emory Brain Health Center - Atlanta

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2021-08-09
Est. Completion 2026-07-31
Phase Phase 4

Sponsor

Emory University

1,208 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06234995

The ClinicalTrials.gov registry entry for NCT06234995 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 5 interventions - of which Levodopa is the first listed.

NCT06234995 reports 2 study locations spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT06234995 about?

NCT06234995 is a clinical study titled "Cortical Electrophysiology of Response Inhibition in Parkinson's Disease". Patients with Parkinson's Disease will be studied before, during, and after a deep brain stimulation implantation procedure to see if the stimulation location and the size of the electrical field produced by subthalamic nucleus (STN) DBS determine the degree to which DBS engages circuits that involv...

What is the current status of trial NCT06234995?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2021-08-09. Estimated completion is 2026-07-31.

What conditions does trial NCT06234995 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT06234995?

The interventions under investigation include: Levodopa (DRUG), Clinical DBS Setting (DEVICE), Sham DBS (DEVICE), DBS Setting Maximizing Prefrontal Activation (DEVICE), DBS Setting Minimizing Prefrontal Activation (DEVICE).

Who is sponsoring clinical trial NCT06234995?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06234995 being conducted?

This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson Disease

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.